Aqemia
PrivateLast Round
Grant
Apr 1, 2025
Total Funding Raised
$70.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aqemia is a pharmatech company that utilizes a platform combining generative AI with quantum-inspired physics to accelerate the discovery of small-molecule drugs.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aqemia Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Aqemia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2025 | ||||
| VC Round | Dec 10, 2024 | ||||
| Series A Extension | Jan 30, 2024 | ||||
| Series A | Oct 19, 2022 | ||||
| Pre Seed | Oct 17, 2019 |
Key People
Founding team and executive leadership
Aqemia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| Wendel Growth | Series A Extension |
| Elaia Partners | Series A, VC Round, Series A Extension, Pre Seed |
| Bpifrance | VC Round, Series A Extension, Pre Seed, Series A |
| Wendel Group | VC Round |
| Bpifrance | Series A |
| Eurazeo | VC Round, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Recognized as a key player in Europe's DeepTech ecosystem.
- Apr 21, 2026
Recognized as a key player in Europe's DeepTech ecosystem.
Aqemia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aqemia's valuation, stock price, and market status.